
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.830 | 1.830 | 0.000 |
Shares | 98.170 | 98.170 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 10.724 | 13.084 |
Price to Book | 1.570 | 1.807 |
Price to Sales | 0.970 | 1.173 |
Price to Cash Flow | 6.676 | 7.626 |
Dividend Yield | 3.426 | 3.033 |
5 Years Earnings Growth | 7.146 | 9.314 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 31.620 | 15.077 |
Communication Services | 15.380 | 8.057 |
Technology | 14.690 | 14.263 |
Consumer Defensive | 9.730 | 9.764 |
Industrials | 9.210 | 12.272 |
Consumer Cyclical | 5.900 | 9.943 |
Financial Services | 5.740 | 18.824 |
Real Estate | 3.720 | 2.245 |
Utilities | 2.450 | 4.550 |
Basic Materials | 0.980 | 5.441 |
Energy | 0.590 | 5.406 |
Number of long holdings: 103
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Johnson & Johnson | - | 3.42 | - | - | |
Cisco Systems Inc | - | 3.33 | - | - | |
KDDI Corp. | JP3496400007 | 3.23 | 2,532.5 | +1.89% | |
Cigna Corp | - | 3.07 | - | - | |
AT&T Inc | - | 2.79 | - | - | |
Comcast Corp Class A | - | 2.75 | - | - | |
NTT Inc | JP3735400008 | 2.61 | 155.9 | +2.10% | |
Oracle Corp | - | 2.58 | - | - | |
Amgen Inc | - | 2.28 | - | - | |
Medtronic | IE00BTN1Y115 | 2.16 | 89.34 | -1.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0607974713 | 7.3B | 9.00 | 10.19 | 10.06 | ||
LU1059906690 | 7.3B | -2.67 | 7.91 | - | ||
Nordea 1 Stable Return Fund HB USD | 2.76B | 1.44 | 3.32 | 3.17 | ||
LU0985320562 | 19.44M | 7.10 | 12.72 | - | ||
N1 Global Stable Equity Fund BI USD | 1.98B | 9.13 | 9.58 | 7.13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review